73 related articles for article (PubMed ID: 18758502)
21. Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice.
Hocher B; Schwarz A; Fagan KA; Thöne-Reineke C; El-Hag K; Kusserow H; Elitok S; Bauer C; Neumayer HH; Rodman DM; Theuring F
Am J Respir Cell Mol Biol; 2000 Jul; 23(1):19-26. PubMed ID: 10873149
[TBL] [Abstract][Full Text] [Related]
22. Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: role of perivascular adipose tissue.
Virdis A; Duranti E; Rossi C; Dell'Agnello U; Santini E; Anselmino M; Chiarugi M; Taddei S; Solini A
Eur Heart J; 2015 Apr; 36(13):784-94. PubMed ID: 24578389
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone.
Deuchar GA; Docherty A; MacLean MR; Hicks MN
Br J Pharmacol; 2002 Feb; 135(4):1060-8. PubMed ID: 11861335
[TBL] [Abstract][Full Text] [Related]
24. Chronic blockade of nitric oxide-synthase and endothelin receptors during pregnancy in the rat: effect on pregnancy outcome.
Wight E; Küng CF; Moreau P; Takase H; Lüscher TF
J Soc Gynecol Investig; 1998; 5(3):132-9. PubMed ID: 9614642
[TBL] [Abstract][Full Text] [Related]
25. Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans.
Thorin E; Parent R; Ming Z; Lavallée M
Am J Physiol; 1999 Aug; 277(2):H524-32. PubMed ID: 10444477
[TBL] [Abstract][Full Text] [Related]
26. Role of NO and endothelin in hemoglobin-induced pulmonary vasoconstriction.
Heller A; Ragaller M; Schmeck J; Flüth H; Müller M; Albrecht DM; Koch T
Shock; 1998 Dec; 10(6):401-6. PubMed ID: 9872678
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism.
Boffa JJ; Tharaux PL; Placier S; Ardaillou R; Dussaule JC; Chatziantoniou C
Circulation; 1999 Nov; 100(18):1901-8. PubMed ID: 10545435
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin.
Ruschitzka FT; Wenger RH; Stallmach T; Quaschning T; de Wit C; Wagner K; Labugger R; Kelm M; Noll G; Rülicke T; Shaw S; Lindberg RL; Rodenwaldt B; Lutz H; Bauer C; Lüscher TF; Gassmann M
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11609-13. PubMed ID: 11027359
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide and endothelin in oxygen-dependent regulation of vascular tone of human umbilical vein.
Mildenberger E; Biesel B; Siegel G; Versmold HT
Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1730-7. PubMed ID: 12969885
[TBL] [Abstract][Full Text] [Related]
30. L-NAME potentiates endothelin-stimulated thromboxane release from guinea pig lung.
Lewis K; Cadieux A; Rae GA; D'Orléans-Juste P
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S109-11. PubMed ID: 9595414
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary perfusion during lipopolysaccharide (LPS) induced fetal endotoxemia in the preterm fetal sheep.
Garnier Y; Coumans AB; Berger R; Hasaart TH
Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):150-7. PubMed ID: 16054285
[TBL] [Abstract][Full Text] [Related]
32. [Nitric oxide and endothelins in pulmonary hypertension].
Aoki Y; Saji T
Nihon Rinsho; 2001 Jun; 59(6):1059-64. PubMed ID: 11411113
[TBL] [Abstract][Full Text] [Related]
33. Effect of inhaled nitric oxide in endothelin-1-induced pulmonary hypertension.
Truog WE; Norberg M; Thibeault DW
Biol Neonate; 1998; 73(4):246-53. PubMed ID: 9551191
[TBL] [Abstract][Full Text] [Related]
34. Regression of renal vascular fibrosis by endothelin receptor antagonism.
Boffa JJ; Tharaux PL; Dussaule JC; Chatziantoniou C
Hypertension; 2001 Feb; 37(2 Pt 2):490-6. PubMed ID: 11230324
[TBL] [Abstract][Full Text] [Related]
35. Transgenic rats expressing the human ET-2 gene: a model for the study of endothelin actions in vivo.
Liefeldt L; Schönfelder G; Böcker W; Hocher B; Talsness CE; Rettig R; Paul M
J Mol Med (Berl); 1999 Jul; 77(7):565-74. PubMed ID: 10494802
[TBL] [Abstract][Full Text] [Related]
36. The influence of a nitric oxide synthase inhibitor and endothelin receptor blocker on the free sulfhydryl groups content in lung homogenates.
Kleniewska P; Gorąca A
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1539-43. PubMed ID: 27259226
[TBL] [Abstract][Full Text] [Related]
37. Endothelin in pulmonary fibrosis.
Fonseca C; Abraham D; Renzoni EA
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):1-10. PubMed ID: 20448055
[TBL] [Abstract][Full Text] [Related]
38. Renal phenotype of ET-1 transgenic mice is modulated by androgens.
Kalk P; Thöne-Reineke C; Schwarz A; Godes M; Bauer C; Pfab T; Hocher B
Eur J Med Res; 2009; 14(2):55-8. PubMed ID: 19258213
[TBL] [Abstract][Full Text] [Related]
39. Adhesion molecules and microvascular changes in the nonobese diabetic (NOD) mouse pancreas. An NO-inhibitor (L-NAME) is unable to block adhesion inflammation-induced activation.
Papaccio G; Latronico MV; Pisanti FA; Federlin K; Linn T
Autoimmunity; 1998; 27(2):65-77. PubMed ID: 9583738
[TBL] [Abstract][Full Text] [Related]
40. A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis.
Teder P; Noble PW
Am J Respir Cell Mol Biol; 2000 Jul; 23(1):7-10. PubMed ID: 10873147
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
